New Mexico § 26-4-3 Advisory committee created; membership; duties

New Mexico Statutes

§ 26-4-3 — Advisory committee created; membership; duties

New Mexico § 26-4-3

Ch. 26Drugs and Cosmetics

Art. 4Wholesale Prescription Drug Importation

This text of New Mexico § 26-4-3 (Advisory committee created; membership; duties) is published on Counsel Stack Legal Research, covering New Mexico primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook

N.M. Stat. Ann. § 26-4-3 (2026).

Text

A. The "prescription drug importation advisory committee" is created as an interagency advisory committee of the health care authority. The committee consists of:

(1)the secretary of health care authority, who shall serve as the chair of the committee;

(2)the executive director of the board of pharmacy;

(3)the superintendent of insurance;

(4)the secretary of health; and (5) the secretary of general services. B. Members may appoint designees. C. The committee shall advise the health care authority in developing and implementing the program. The committee shall consult with interested stakeholders and appropriate federal officials as necessary in shaping its advice to the authority. The health care authority shall hold a public hearing on the proposed program prior to submitting the prog

Free access — add to your briefcase to read the full text and ask questions with AI

A. The "prescription drug importation advisory committee" is created as an interagency advisory committee of the health care authority. The committee consists of: (1) the secretary of health care authority, who shall serve as the chair of the committee; (2) the executive director of the board of pharmacy; (3) the superintendent of insurance; (4) the secretary of health; and (5) the secretary of general services. B. Members may appoint designees. C. The committee shall advise the health care authority in developing and implementing the program. The committee shall consult with interested stakeholders and appropriate federal officials as necessary in shaping its advice to the authority. The health care authority shall hold a public hearing on the proposed program prior to submitting the program for federal approval.